Breakthrough Pain Clinical Trial
Official title:
Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units
Patients treated in Palliative Care Units are potentially fragile patients, especially in our
case, which are cancer patients. The management of these patients is usually done from
experience, because these patients rarely meet criteria for clinical trials, as their
inclusion could affect results obtained in the trial.
There is insufficient clinical information on the quality of life of cancer patients with
breakthrough pain treated in palliative care units according to routine clinical practice.
For this reason we consider it is appropriate to prospectively evaluate the quality of life
of cancer patients with cancer breakthrough pain treated in palliative care units as well as
the characteristics of these patients.
This post-authorization observational study will assess the quality of life of patients with
breakthrough cancer pain treated in Palliative Care Units in Spanish hospitals.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00994760 -
Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years
|
N/A | |
| Completed |
NCT01842893 -
Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer
|
Phase 3 | |
| Completed |
NCT02886286 -
Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back Pain
|
Phase 4 | |
| Completed |
NCT02869321 -
Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional Gastrostomy
|
Phase 4 | |
| Completed |
NCT02437929 -
Procedural Pain in Palliative Care: Prevalence, Intensity and Treatment
|
N/A | |
| Completed |
NCT00236145 -
Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough Pain
|
Phase 3 | |
| Completed |
NCT02836379 -
Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative Intent
|
N/A | |
| Active, not recruiting |
NCT02278601 -
Comparison of Regimens MPIB, CIPCEA, PCEA
|
Phase 3 | |
| Terminated |
NCT00842829 -
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
|
Phase 4 | |
| Recruiting |
NCT05200806 -
A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After Colectomy
|
Phase 4 | |
| Withdrawn |
NCT03809455 -
Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
|
Phase 2 | |
| Completed |
NCT03435120 -
Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)
|
||
| Completed |
NCT02050503 -
Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis
|
N/A | |
| Terminated |
NCT00387010 -
Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
|
Phase 3 | |
| Withdrawn |
NCT05053308 -
Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
|
N/A | |
| Recruiting |
NCT04011150 -
Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour
|
Phase 3 | |
| Terminated |
NCT01901718 -
An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.
|
N/A | |
| Completed |
NCT00402350 -
Staccato Fentanyl Single and Multidose PK
|
Phase 1 | |
| Completed |
NCT00236041 -
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
|
Phase 2 |